Wednesday 16 July 2014 13:30 – 15:00
Track 2 - Phosphodiesterase 4 inhibitors as novel anti-inflammatory drugs
Chair: Eeva Moilanen & Heikki Vapaatalo
Phosphodiesterase 4 inhibitors as anti-inflammatory drugs
Heikki Vapaatalo
Phosphodiesterase inhibitors as novel treatments for asthma and COPD
Domenico Spina
PDE4 inhibitors in the treatment of arthritis and psoriasis
Georg Schett
Anti-inflammatory mechanisms of PDE4 inhibitors: role of MAP kinase phosphatase-1
Eeva Moilanen